Results 91 to 100 of about 750,934 (136)

Iron diminishes immunosuppressive macrophages and enhances anti-PD-1 immunotherapy in breast cancer models. [PDF]

J Exp Clin Cancer Res
Wang Q, Adams EL, Poole RA, Soleimani T, Wang GX, Li H, Capitano ML, Masood A, Abrams SI, Lee KP, Zhang S, Opyrchal M.   +11 more
europepmc   +1 more source

PD‐1/PD‐L1

The Japanese Journal of SURGICAL METABOLISM and NUTRITION, 2019
openaire   +2 more sources

Resistance to anti-PD-1 immunotherapy for stage III and IV melanoma: a global chart review study. [PDF]

J Immunother Cancer
Gaughan EM, Kim M, Mendez I, Rao AD, Wei M, So A, Zhong X, Berking C, Jiang R, Kim TM, Dalle S, Robert C, Danson S, Alam S, Charles J, Davies T, Debus D, Dzienis M, Frazer R, Gebhardt C, Geidel G, Hassel JC, Hansen I, Heppt MV, Hildebrandt L, Isaacs JM, Suh KJ, Keam B, Kim YJ, Lesimple T, Saiag P, Delibes A, Barnett R, Krepler C, Gandhi K, Qizilbash N, Shui IM, Tan XL, Sullivan RJ.   +38 more
europepmc   +1 more source

Advances in the application of PD-1/PD-L1 immunotherapy for prostate cancer: a review. [PDF]

Front Immunol
Hu G, Li Z, Chen Y, Liao H, Zhou S.
europepmc   +1 more source

PD-1/PD-L1 inhibitors in recurrent or metastatic nasopharyngeal carcinoma: A systematic review and meta-analysis. [PDF]

Medicine (Baltimore)
Bai W, Xu S, Miao L, Zhao J, Zhao L, Gao Z, Liu T.   +6 more
europepmc   +1 more source

PD-1 blockade does not enhance alloimmunization after allogeneic dendritic cell vaccination in cancer patients. [PDF]

Front Immunol
Planel S, Vayssière G, Maggipinto G, Leplus E, Laulagnier K, Renard F, Myster F, Gerard M, Demedts I, Cuppens K, Pons-Tostivint E, Wauters E, Borm FJ, Sibille A, Colinet B, Pérol M, Theelen WSME, Biesma B, Van De Kerkhove C, Buchmeier E, Althoff FC, Derijcke S, Moro-Sibilot D, Cantero F, Chaperot L, Saas P, Skrzypski M, Vansteenkiste J, Plumas J.   +28 more
europepmc   +1 more source

Effect of the Addition of Xianglian Granules to PD-1 Monoclonal Antibodies in Pancancer Patients. [PDF]

Biol Proced Online
Wu T, Li S, Shuang H, Li Y, Fu S, Jiang H, Zhang S, Du B, Lv J, Xia X, Cao S, Yao L, Pan P, Feng S, Li C, Zhou Z, Chen J, Zhong Y.   +17 more
europepmc   +1 more source

Research progress on the molecular mechanisms of PD-1 and LAG-3 synergy in regulating T cell exhaustion and immunotherapy. [PDF]

Ann Med
Li M, Duan D, Liu C, Xiong Q.
europepmc   +1 more source

PD-1 suppresses CAR signaling by forming the inhibitory signalosome colocalizing to CAR microclusters. [PDF]

Commun Biol
Yoshida Y, Machiyama H, Wakamatsu E, Saito K, Takeuchi A, Nishikawa T, Matsushima R, Nishi W, Nishijima H, Kanno Y, Yokosuka T.   +10 more
europepmc   +1 more source